Jirawat Pratoomwun
Samut Prakan, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients.
Journal: Frontiers in immunology
Published: January 30, 2021
Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01.
Journal: Frontiers in immunology
Published: January 26, 2021
HLA Class-II‒Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients.
Journal: The Journal of investigative dermatology
Published: August 04, 2020
Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.
Journal: Clinical pharmacology and therapeutics
Published: December 10, 2019
Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population.
Journal: Pharmacogenetics and genomics
Published: September 09, 2017
Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients.
Journal: Frontiers in pharmacology
Published: June 30, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026